Tissue engineering in Vivo with vascularized scaffolds
    1.
    发明授权
    Tissue engineering in Vivo with vascularized scaffolds 有权
    组织工程在体内与血管支架

    公开(公告)号:US08192487B2

    公开(公告)日:2012-06-05

    申请号:US12945618

    申请日:2010-11-12

    IPC分类号: A61F2/12 A61F2/00

    摘要: The field of the present invention relates to a novel method for producing tissue or organ in a mammal by implanting in vivo a novel three dimensional biodegradable scaffold. The novel three dimensional biodegradable scaffolds overcome the barrier of developing large organs with tissue engineering.

    摘要翻译: 本发明的领域涉及通过在体内植入新的三维可生物降解的支架来在哺乳动物中产生组织或器官的新方法。 新型三维可生物降解支架克服了组织工程开发大器官的障碍。

    Tissue Engineering In Vivo With Vascularized Scaffolds
    2.
    发明申请
    Tissue Engineering In Vivo With Vascularized Scaffolds 有权
    组织工程体内血管化支架

    公开(公告)号:US20110106250A1

    公开(公告)日:2011-05-05

    申请号:US12945618

    申请日:2010-11-12

    IPC分类号: A61F2/12

    摘要: The field of the present invention relates to a novel method for producing tissue or organ in a mammal by implanting in vivo a novel three dimensional biodegradable scaffold. The novel three dimensional biodegradable scaffolds overcome the barrier of developing large organs with tissue engineering.

    摘要翻译: 本发明的领域涉及通过在体内植入新的三维可生物降解的支架来在哺乳动物中产生组织或器官的新方法。 新型三维可生物降解支架克服了组织工程开发大器官的障碍。

    Orally available light-independent antineoplastic compounds
    3.
    发明申请
    Orally available light-independent antineoplastic compounds 审中-公开
    口服可用的光独立抗肿瘤化合物

    公开(公告)号:US20070299046A1

    公开(公告)日:2007-12-27

    申请号:US11474890

    申请日:2006-06-26

    CPC分类号: C07D487/22

    摘要: Pheophorbide derivative compounds which can inhibit cell proliferation and angiogenesis in a light-independent manner are disclosed and claimed. Importantly, these compounds exhibit low toxicity, and are orally/subcutaneous/intravenously/transdermally/topically available, thus having value as new potential agents to treat cancer or diseases related to imbalance in cell proliferation and angiogenesis.

    摘要翻译: 公开并要求保护的,可以以光无关的方式抑制细胞增殖和血管生成的异佛波生物衍生物化合物。 重要的是,这些化合物显示低毒性,并且是口服/皮下/静脉内/经皮/局部可用的,因此具有治疗癌症或与细胞增殖和血管发生不平衡有关的疾病的新潜在药物的价值。

    Tissue engineering in vivo with vascularized scaffolds
    4.
    发明申请
    Tissue engineering in vivo with vascularized scaffolds 有权
    组织工程在体内与血管化支架

    公开(公告)号:US20080090292A1

    公开(公告)日:2008-04-17

    申请号:US11973812

    申请日:2007-10-09

    IPC分类号: C12N5/00 A61F2/02

    摘要: The field of the present invention relates to a novel method for producing tissue or organ in a mammal by implanting in vivo a novel three dimensional biodegradable scaffold. The novel three dimensional biodegradable scaffolds overcome the barrier of developing large organs with tissue engineering.

    摘要翻译: 本发明的领域涉及通过在体内植入新的三维可生物降解的支架来在哺乳动物中产生组织或器官的新方法。 新型三维可生物降解支架克服了组织工程开发大器官的障碍。

    Tissue engineering in vivo with vascularized scaffolds
    5.
    发明授权
    Tissue engineering in vivo with vascularized scaffolds 有权
    组织工程在体内与血管化支架

    公开(公告)号:US07846728B2

    公开(公告)日:2010-12-07

    申请号:US11973812

    申请日:2007-10-09

    IPC分类号: C12N5/00 A61F2/02

    摘要: The field of the present invention relates to a novel method for producing tissue or organ in a mammal by implanting in vivo a novel three dimensional biodegradable scaffold. The novel three dimensional biodegradable scaffolds overcome the barrier of developing large organs with tissue engineering.

    摘要翻译: 本发明的领域涉及通过在体内植入新的三维可生物降解的支架来在哺乳动物中产生组织或器官的新方法。 新型三维可生物降解支架克服了组织工程开发大器官的障碍。